Macquarie Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-139,544
Closed -$7.56M 945
2025
Q3
$7.56M Buy
139,544
+15,900
+13% +$909K 0.01% 866
2025
Q2
$6.8M Buy
123,644
+5,800
+5% +$342K 0.01% 903
2025
Q1
$8.33M Sell
117,844
-3,520
-3% -$237K 0.01% 844
2024
Q4
$7.98M Buy
121,364
+749
+0.6% +$50.2K 0.01% 852
2024
Q3
$8.48M Hold
120,615
0.01% 851
2024
Q2
$9.93M Buy
120,615
+2,003
+2% +$167K 0.01% 817
2024
Q1
$10.4M Hold
118,612
0.01% 813
2023
Q4
$11.4M Sell
118,612
-11,653
-9% -$1.03M 0.01% 792
2023
Q3
$11.5M Buy
130,265
+1,146
+0.9% +$102K 0.01% 753
2023
Q2
$11.2M Sell
129,119
-240
-0.2% -$22.6K 0.01% 763
2023
Q1
$12.6M Hold
129,359
0.01% 762
2022
Q4
$13.4M Buy
129,359
+399
+0.3% +$37.5K 0.02% 777
2022
Q3
$10.9M Sell
128,960
-764
-0.6% -$68K 0.01% 814
2022
Q2
$10.7M Sell
129,724
-24,040
-16% -$1.91M 0.01% 849
2022
Q1
$11.9K Sell
153,764
-67,637
-31% -$5.66M 0.01% 897
2021
Q4
$19.6M Sell
221,401
-3,520
-2% -$290K 0.02% 755
2021
Q3
$17.4M Sell
224,921
-126
-0.1% -$9.94K 0.01% 805
2021
Q2
$18.8M Buy
225,047
+1,500
+0.7% +$119K 0.02% 800
2021
Q1
$16.9M Sell
223,547
-15,524
-6% -$1.27M 0.02% 582
2020
Q4
$21M Sell
239,071
-2,780
-1% -$220K 0.03% 504
2020
Q3
$18.4M Buy
241,851
+24,322
+11% +$2.46M 0.03% 491
2020
Q2
$26.8M Buy
217,529
+889
+0.4% +$88.4K 0.05% 402
2020
Q1
$18.3M Sell
216,640
-4,900
-2% -$422K 0.04% 435
2019
Q4
$18.7M Sell
221,540
-1,840
-0.8% -$139K 0.03% 530
2019
Q3
$15.1M Hold
223,380
0.03% 516
2019
Q2
$19.1M Buy
223,380
+20,530
+10% +$1.76M 0.03% 471
2019
Q1
$18M Buy
202,850
+5,790
+3% +$537K 0.03% 487
2018
Q4
$16.8M Sell
197,060
-4,240
-2% -$403K 0.03% 470
2018
Q3
$19.5M Buy
201,300
+39,170
+24% +$3.91M 0.03% 486
2018
Q2
$15.3M Buy
162,130
+160,430
+9,437% +$14M 0.03% 539
2018
Q1
$138K Sell
1,700
-3,500
-67% -$300K ﹤0.01% 1809
2017
Q4
$379K Sell
5,200
-35,513
-87% -$3.09M ﹤0.01% 1528
2017
Q3
$3.79M Sell
40,713
-3,439
-8% -$304K 0.01% 823
2017
Q2
$4.01M Sell
44,152
-11,231
-20% -$1.02M 0.01% 804
2017
Q1
$4.86M Sell
55,383
-27,173
-33% -$2.42M 0.01% 752
2016
Q4
$6.84M Sell
82,556
-39,028
-32% -$3.36M 0.01% 672
2016
Q3
$11.2M Sell
121,584
-33,330
-22% -$3.14M 0.02% 571
2016
Q2
$12.1M Buy
154,914
+29,471
+23% +$2.51M 0.01% 666
2016
Q1
$10.3M Buy
125,443
+67,893
+118% +$5.52M 0.02% 545
2015
Q4
$6.03M Sell
57,550
-9,400
-14% -$982K 0.01% 662
2015
Q3
$7.05M Sell
66,950
-12,950
-16% -$1.73M 0.02% 635
2015
Q2
$10.9M Buy
79,900
+16,400
+26% +$2.03M 0.02% 513
2015
Q1
$7.91M Buy
63,500
+60,300
+1,884% +$6.39M 0.02% 610
2014
Q4
$289K Hold
3,200
﹤0.01% 1357
2014
Q3
$231K Sell
3,200
-10,000
-76% -$657K ﹤0.01% 1377
2014
Q2
$821K Sell
13,200
-4,500
-25% -$272K ﹤0.01% 1232
2014
Q1
$1.21M Hold
17,700
﹤0.01% 1128
2013
Q4
$1.24M Sell
17,700
-16
-0.1% -$1.09K ﹤0.01% 1111
2013
Q3
$1.28M Sell
17,716
-284
-2% -$18.9K ﹤0.01% 1098
2013
Q2
$1M Buy
+18,000
New +$1.12M ﹤0.01% 1155

Other funds holding BMRN